Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
Tenaya Therapeutics (TNYA) Stock Price & Analysis
72 Followers
TNYA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.64 - $16.17
Previous Close$3.42
Volume257.80K
Average Volume (3M)322.39K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$149.45M
Total Debt (Recent Filing)$16.06M
Price to Earnings (P/E)-1.2
Beta1.47
Next EarningsMar 22, 2023
EPS Estimate-$0.63
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$20.80
EPS (TTM)-2.81
Shares Outstanding63,987,996
R-Squared0.28
Standard Deviation0.19
10 Day Avg. Volume281,741
30 Day Avg. Volume322,386
Price to Book (P/B)0.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside508.19% Upside
Rating ConsensusStrong Buy
Alpha-0.09
Number of Analyst Covering5
Tenaya Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNYA FAQ
What was Tenaya Therapeutics’s price range in the past 12 months?
Tenaya Therapeutics lowest stock price was $1.64 and its highest was $16.17 in the past 12 months.
What is Tenaya Therapeutics’s market cap?
Currently, no data Available
When is Tenaya Therapeutics’s upcoming earnings report date?
Tenaya Therapeutics’s upcoming earnings report date is Mar 22, 2023 which is in 53 days.
How were Tenaya Therapeutics’s earnings last quarter?
Tenaya Therapeutics released its earnings results on Nov 10, 2022. The company reported -$0.74 earnings per share for the quarter, missing the consensus estimate of -$0.655 by -$0.085.
Is Tenaya Therapeutics overvalued?
According to Wall Street analysts Tenaya Therapeutics’s price is currently Undervalued.
Does Tenaya Therapeutics pay dividends?
Tenaya Therapeutics does not currently pay dividends.
What is Tenaya Therapeutics’s EPS estimate?
Tenaya Therapeutics’s EPS estimate is -$0.63.
How many shares outstanding does Tenaya Therapeutics have?
Tenaya Therapeutics has 63,987,995 shares outstanding.
What happened to Tenaya Therapeutics’s price movement after its last earnings report?
Tenaya Therapeutics reported an EPS of -$0.74 in its last earnings report, missing expectations of -$0.655. Following the earnings report the stock price went up 30.882%.
Which hedge fund is a major shareholder of Tenaya Therapeutics?
Among the largest hedge funds holding Tenaya Therapeutics’s share is RA Capital Management. It holds Tenaya Therapeutics’s shares valued at 5M.
---
Tenaya Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.80
$20.80
Hedge Fund Trend
Decreased
By 1.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $58.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.2%
Last 30 Days ▲ 36.5%
Last 30 Days ▲ 36.5%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.30%
12-Months-Change
Fundamentals
Return on Equity
-46.52%
Trailing 12-Months
Asset Growth
-31.79%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tenaya Therapeutics
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
---
---